April 4, 2025
New questions that need to be asked
In a few weeks companies will begin reporting first quarter earnings. Earnings which will NOT reflex the tariffs put in place by President Trump. Nor will they reflex the dramatic cuts made at the FDA. Yet these two items must be addressed as they are sure to have an impact on future results. Just how dramatic is open to conjecture which is why questions need to be asked.
Let’s look at the cuts at the FDA first which hit diabetes hard. The FDA approval process has never been quick or easy. We find it difficult to believe the . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.
